Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratoses
Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratoses
September 24, 2018 (Issue: 1556)
The FDA has approved hydrogen peroxide 40% topical
solution (Eskata – Aclaris Therapeutics) for treatment
of raised seborrheic keratoses (SKs) in adults. It is the
first drug to be approved for this indication. (Hydrogen
peroxide is available...more
- GC Ranasinghe and AJ Friedman. Managing seborrheic keratoses: evolving strategies for optimizing patient outcomes. J Drugs Dermatol 2017; 16:1064.
- JM Jackson et al. Current understanding of seborrheic keratosis: prevalence, etiology, clinical presentation, diagnosis, and management. J Drugs Dermatol 2015; 14:1119.
- JC DuBois et al. A-101, a proprietary topical formulation of high-concentration hydrogen peroxide solution: a randomized, double-blind, vehicle-controlled, parallel group study of the dose–response profile in subjects with seborrheic keratosis of the face. Dermatol Surg 2018; 44:330.
- LS Baumann et al. Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w) in patients with seborrheic keratoses: results from two identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302). J Am Acad Dermatol 2018 June 1 (epub).
- Approximate WAC. WAC = wholesaler acquisition cost, or manufacturer's published price to wholesalers; WAC represents published catalogue or list prices and may not represent an actual transactional price. Source: AnalySource® Monthly. September 5, 2018. Reprinted with permission by First Databank, Inc. All rights reserved. ©2018. www.fdbhealth.com/policies/drug-pricing-policy.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratoses
Article code: 1556b
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
